68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:July 13, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:July 13, 2023Recruiting
Condition(s):Metastatic Clear Cell Renal Cell CarcinomaLast Updated:July 24, 2023Recruiting
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:March 9, 2022Recruiting
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:July 13, 2023Recruiting
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:October 26, 2023Recruiting
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:September 28, 2023Recruiting
Condition(s):Clear Cell Renal Cell CarcinomaLast Updated:March 1, 2024Recruiting
Condition(s):Clear Cell Renal Cell Carcinoma、Resistance to ImmunotherapyLast Updated:September 13, 2023Recruiting
Condition(s):Advanced/Metastatic Clear Cell Renal Cell CarcinomaLast Updated:October 31, 2023Recruiting
Condition(s):Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid TumorsLast Updated:March 7, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.